DLB stands for dementia with Lewy bodies, the second most common type of progressive dementia after Alzheimer’s disease. It accounts for roughly 5% of all dementia cases in older adults. The condition is caused by abnormal clumps of a protein called alpha-synuclein that build up inside nerve cells in the brain, forming structures known as Lewy bodies. These deposits damage and eventually kill neurons, leading to a distinctive combination of cognitive, movement, sleep, and psychiatric symptoms that sets DLB apart from other forms of dementia.
What Happens in the Brain
In DLB, alpha-synuclein protein misfolds and accumulates inside vulnerable brain cells. The amygdala, a region involved in emotion and memory processing, appears to be one of the first places these deposits form. From there, the pathology spreads outward into surrounding limbic structures and eventually into the outer layers of the brain (the neocortex), which handle complex thinking, perception, and language. Some researchers believe the abnormal protein may initially reach the brain through the olfactory bulb, the area responsible for your sense of smell, which could explain why many people with DLB notice a decline in their ability to detect odors early on.
This spreading pattern is important because it explains why DLB symptoms unfold in a particular order and why certain brain functions are hit harder than others. Unlike Alzheimer’s, where memory loss tends to dominate early, DLB often first disrupts attention, visual processing, and the brain’s ability to regulate alertness.
The Four Core Symptoms
DLB is defined by four core clinical features. Not every person develops all four, but most experience at least two:
- Fluctuating cognition. Attention and alertness shift dramatically, sometimes within the same day. A person might seem sharp and engaged one hour, then confused and drowsy the next. These swings can look like delirium to family members and even to clinicians unfamiliar with DLB.
- Recurrent visual hallucinations. These are typically vivid, detailed, and well-formed. People commonly see other people (familiar or unfamiliar, living or dead), animals, insects, or children. Some experience subtler phenomena first: a fleeting shadow passing at the edge of their vision, or the strong sense that someone else is in the room. Unlike the vague, fragmented hallucinations seen in some other conditions, DLB hallucinations often look completely real to the person experiencing them.
- REM sleep behavior disorder. During normal REM sleep, the body is temporarily paralyzed so you don’t physically act out your dreams. In DLB, that paralysis fails. People punch, kick, shout, or leap out of bed while dreaming, sometimes injuring themselves or a bed partner. Up to 76% of people with DLB develop this symptom, and critically, it often begins years or even decades before any cognitive decline appears. It is one of the strongest early warning signs of the disease.
- Parkinsonism. Slowed movement, muscle rigidity, resting tremor, and shuffling gait can all appear. These motor symptoms overlap heavily with Parkinson’s disease, which creates a diagnostic challenge.
How DLB Differs From Parkinson’s Disease Dementia
DLB and Parkinson’s disease dementia (PDD) are closely related. Both involve alpha-synuclein deposits and share many symptoms. The clinical distinction comes down to timing: if cognitive problems appear before or within one year of movement symptoms, the diagnosis is DLB. If movement symptoms came first and dementia developed at least a year later, the diagnosis is PDD. This is sometimes called the “one-year rule.” The underlying biology is likely a spectrum, but the distinction matters because the two conditions can follow different trajectories and respond differently to treatment.
Getting a Diagnosis
No single test confirms DLB during a person’s lifetime. Diagnosis is based on the pattern of symptoms, but imaging can help. A DaTSCAN, which measures dopamine-related activity in the brain, is one of the most useful tools for telling DLB apart from Alzheimer’s. A meta-analysis of published studies found DaTSCAN correctly identified DLB about 87% of the time and correctly ruled it out about 94% of the time. Sleep studies can confirm REM sleep behavior disorder, and certain patterns on EEG or brain imaging can add supporting evidence. Still, DLB is widely underdiagnosed, partly because its symptoms overlap with Alzheimer’s, Parkinson’s, and even psychiatric conditions.
Treatment and Medication Safety
There is no cure for DLB, and treatment focuses on managing symptoms. The first-line medications are cholinesterase inhibitors, drugs that boost levels of a brain chemical involved in memory and attention. These can improve cognitive function, reduce hallucinations and delusions, and in many cases do so without worsening movement symptoms. The response tends to be better in DLB than in Alzheimer’s, likely because the cholinergic deficit in DLB is more pronounced.
One of the most important things to know about DLB is its dangerous sensitivity to certain psychiatric medications. An estimated 30 to 50% of people with DLB experience severe reactions when given standard antipsychotic drugs, even at low doses. These reactions can worsen tremor, rigidity, confusion, and hallucinations. In some cases they trigger neuroleptic malignant syndrome, a life-threatening condition involving extreme muscle rigidity, fever, and altered consciousness. Traditional antipsychotics like haloperidol carry the highest risk. If antipsychotic medication is genuinely needed, only certain lower-risk options should be considered, and only at very low doses with careful monitoring.
This sensitivity makes accurate diagnosis essential. A person with DLB who is misdiagnosed with Alzheimer’s or a psychiatric disorder could easily be prescribed a medication that makes them dramatically worse.
What to Expect Over Time
DLB is progressive, meaning symptoms worsen over time. On average, people live five to eight years after diagnosis, though some live much longer. The rate of decline varies considerably from person to person. Cognitive fluctuations can make the early years particularly disorienting for families, because good days can create false hope that the person is improving. As the disease advances, mobility problems tend to increase, hallucinations may become more frequent, and the person gradually needs more help with daily activities.
Caregiving for someone with DLB can be especially challenging because of the combination of cognitive, psychiatric, and motor symptoms. The hallucinations and sleep disturbances, in particular, create a very different caregiving experience than Alzheimer’s disease, and support groups specific to Lewy body dementia can be more helpful than general dementia resources.